Clearside Biomedical Inc 's ability to collect accounts receivable sequentially worsen to 4.26, indicating more challenging environment then in the second quarter 2025, but still, it is a far cry from any concerns. Clearside Biomedical Inc 's Accounts Receivable average collection period in the Sep 30 2025 quarter, has increased to 86 days, from 80 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 424 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2025 from 2473 to 2801.

What is Receivable Turnover Ratio?
What is Clearside Biomedical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CLSD Receivables Turnover Ratio	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-66.24 %	-	-	198.24 %	-10.66 %
Y / Y Revenue Change	-80.64 %	446.67 %	913.04 %	-95.18 %	20.84 %
Receivable Turnover Ratio (TTM)	4.26	4.57	5.31	5.14	32.16
CLSD's Total Ranking	# 2801	# 2473	# 2544	# 2493	# 2543
Accounts Receivable average collection period days	86	80	69	71	11
Seq. Receivable Change	-67.4 %	-46.94 %	203.35 %	-35.66 %	-
Seq. Revenue Change	-59.15 %	-78.88 %	661.44 %	-70.52 %	1053.33 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 141
Healthcare Sector	# 425
Overall Market	# 2801

Receivable Turnover Ratio Statistics
High	Average	Low
0.93	0.26	0
(Dec 31 2021)		(Sep 30 2019)

CLSD Company Profile • Back to CLSD Efficiency Comparisons • Compare CLSD Receivables Turnover Ratio to its Competitors

Financial Statements
Clearside Biomedical Inc 's Accounts Receivable	$ 0 Millions	Visit CLSD's Balance sheet
Clearside Biomedical Inc 's Sales TTM	$ 3 Millions	Visit CLSD's Income Statement
Sources of CLSD's Revenues		Visit CLSD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CLSD's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CLSD's Growth Rates	CLSD's Roa	CLSD's Inventory Turnover Ratio	CLSD's Dividend Comparisons
CLSD's Profitability Ratios	CLSD's Roi	CLSD's Asset Turnover Ratio	CLSD's Dividend Growth
CLSD's Valuation Ratios	CLSD's Roe	CLSD's Financial Strength Ratios	CLSD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2025	Receivable at quarter ending Sep 30 2025
Wave Life Sciences Ltd	33.51	$ 109.230 Millions	$ 3.260 Millions
Lipocine Inc	32.23	$ 4.323 Millions	$ 0.134 Millions
Invo Fertility Inc	32.11	$ 6.944 Millions	$ 0.216 Millions
Metagenomi Therapeutics Inc	30.14	$ 30.913 Millions	$ 1.025 Millions
Longeveron Inc	29.33	$ 1.437 Millions	$ 0.049 Millions
U S Physical Therapy Inc	29.22	$ 758.711 Millions	$ 25.966 Millions
Lifemd Inc	28.68	$ 250.860 Millions	$ 8.746 Millions
Innovative Eyewear Inc	28.24	$ 2.393 Millions	$ 0.085 Millions
Polomar Health Services, Inc.	27.46	$ 0.037 Millions	$ 0.001 Millions
Keros Therapeutics Inc	27.14	$ 266.962 Millions	$ 9.835 Millions
Cv Sciences Inc	24.73	$ 11.758 Millions	$ 0.476 Millions
Aquestive Therapeutics Inc	23.64	$ 43.397 Millions	$ 1.836 Millions
Aim Immunotech Inc	23.58	$ 0.112 Millions	$ 0.005 Millions
Safe Pro Group Inc	23.20	$ 1.267 Millions	$ 0.055 Millions
Fonar Corporation	22.87	$ 105.434 Millions	$ 4.609 Millions
Electrocore Inc	22.58	$ 28.883 Millions	$ 1.279 Millions
Immunocore Holdings Plc	22.33	$ 379.590 Millions	$ 16.997 Millions
Innovage Holding Corp	21.40	$ 884.662 Millions	$ 41.330 Millions
Orthofix Medical Inc	21.02	$ 818.516 Millions	$ 38.934 Millions
Arvinas Inc	20.82	$ 312.300 Millions	$ 15.000 Millions
Spero Therapeutics Inc	20.78	$ 40.549 Millions	$ 1.951 Millions
Neuroone Medical Technologies Corp	20.67	$ 9.098 Millions	$ 0.440 Millions
Plus Therapeutics Inc	20.60	$ 5.258 Millions	$ 0.255 Millions
Bioxcel Therapeutics Inc	20.32	$ 0.752 Millions	$ 0.037 Millions
Sonida Senior Living Inc	19.17	$ 375.417 Millions	$ 19.582 Millions
Nutriband Inc	19.13	$ 2.278 Millions	$ 0.119 Millions
Bespoke Extracts Inc	19.07	$ 1.423 Millions	$ 0.075 Millions
Generation Bio Co	18.72	$ 15.270 Millions	$ 0.816 Millions
Neuraxis Inc	18.54	$ 3.362 Millions	$ 0.181 Millions
Siga Technologies Inc	18.46	$ 172.250 Millions	$ 9.332 Millions

Date modified: 2026-08-29T17:36:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.